Biotech giant Amgen could be nearing a deal to buy Alexion Pharmaceuticals at a 74% premium, according to a Spanish news outlet. The deal would value Alexion stock at $200 per share.

source https://finance.yahoo.com/m/c222d264-0871-3e5a-9485-eccbded6520a/biotech-giant-amgen-could-be.html?.tsrc=rss